Cargando…
The Road to Personalized Medicine in Alzheimer’s Disease: The Use of Artificial Intelligence
Dementia remains an extremely prevalent syndrome among older people and represents a major cause of disability and dependency. Alzheimer’s disease (AD) accounts for the majority of dementia cases and stands as the most common neurodegenerative disease. Since age is the major risk factor for AD, the...
Autores principales: | Silva-Spínola, Anuschka, Baldeiras, Inês, Arrais, Joel P., Santana, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869403/ https://www.ncbi.nlm.nih.gov/pubmed/35203524 http://dx.doi.org/10.3390/biomedicines10020315 |
Ejemplares similares
-
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
por: Leitão, Maria João, et al.
Publicado: (2019) -
Artificial intelligence, radiology, precision medicine, and personalized medicine
por: Leite, Claudia da Costa
Publicado: (2019) -
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
por: Baldeiras, Inês, et al.
Publicado: (2019) -
Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine
por: Sotoudeh, Houman, et al.
Publicado: (2019) -
Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine
por: Ahn, Jong Seok, et al.
Publicado: (2023)